Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) (clinicaltrials.gov) - Oct 27, 2026 - P3 | N=1068 | Active, not recruiting | Sponsor: Pfizer | Trial completion date: Sep 2026 ➔ Jul 2027
Monotherapy • Trial completion date • Genito-urinary Cancer • Hormone Sensitive Prostate Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
|